These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 10482954)
1. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease. Tilley L; Morgan K; Grainger J; Marsters P; Morgan L; Lowe J; Xuereb J; Wischik C; Harrington C; Kalsheker N Eur J Hum Genet; 1999 Sep; 7(6):659-63. PubMed ID: 10482954 [TBL] [Abstract][Full Text] [Related]
2. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease. Cui T; Zhou X; Jin W; Zheng F; Cao X Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232 [TBL] [Abstract][Full Text] [Related]
3. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study. Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903 [TBL] [Abstract][Full Text] [Related]
4. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease. Raygani AV; Zahrai M; Soltanzadeh A; Doosti M; Javadi E; Pourmotabbed T Neurosci Lett; 2004 Nov; 371(2-3):142-6. PubMed ID: 15519745 [TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913 [TBL] [Abstract][Full Text] [Related]
6. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease. Beyer K; Lao JI; Latorre P; Ariza A Ann N Y Acad Sci; 2005 Dec; 1057():260-78. PubMed ID: 16399900 [TBL] [Abstract][Full Text] [Related]
7. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112 [TBL] [Abstract][Full Text] [Related]
8. [Analysis of the interaction of the polymorphisms of presenilin-1 gene and ApoE gene in Alzheimerns disease]. Ma Q; Qian C; Liu Z Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Dec; 17(6):390-4. PubMed ID: 11110974 [TBL] [Abstract][Full Text] [Related]
9. No association between the intronic presenilin 1 polymorphism and Alzheimer's disease in the Chinese population. Wu X; Jiang S; Lin S; Tang G; Feng G; Qian Y; Wang D; Ren D; Gu N Am J Med Genet; 1999 Feb; 88(1):1-3. PubMed ID: 10050959 [TBL] [Abstract][Full Text] [Related]
12. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Bullido MJ; Artiga MJ; Recuero M; Sastre I; García MA; Aldudo J; Lendon C; Han SW; Morris JC; Frank A; Vázquez J; Goate A; Valdivieso F Nat Genet; 1998 Jan; 18(1):69-71. PubMed ID: 9425904 [TBL] [Abstract][Full Text] [Related]
14. Association between presenilin 1 intronic polymorphism and late onset Alzheimer's disease in the North Chinese population. Jia L; Zhou C; Lv H; Wang W; Ye J; Zhang X; Zhou W; Xu J; Wang L; Jia J Brain Res; 2006 Oct; 1116(1):201-5. PubMed ID: 16938285 [TBL] [Abstract][Full Text] [Related]
15. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain). Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of multiple presenilin 2 SNPs for association with early-onset sporadic Alzheimer disease. Howell WM; Brookes AJ Am J Med Genet; 2002 Aug; 111(2):157-63. PubMed ID: 12210343 [TBL] [Abstract][Full Text] [Related]
17. No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples. Fallin D; Gauntlett AC; Scibelli P; Cai X; Duara R; Gold M; Crawford F; Mullan M Genet Epidemiol; 1997; 14(3):299-305. PubMed ID: 9181358 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease. Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159 [TBL] [Abstract][Full Text] [Related]
19. E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles. Lendon CL; Martinez A; Behrens IM; Kosik KS; Madrigal L; Norton J; Neuman R; Myers A; Busfield F; Wragg M; Arcos M; Arango Viana JC; Ossa J; Ruiz A; Goate AM; Lopera F Hum Mutat; 1997; 10(3):186-95. PubMed ID: 9298817 [TBL] [Abstract][Full Text] [Related]